Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2025 / September / Diagnostics Interoperability and the AMR Challenge / Summary
Microbiology & Immunology Screening and monitoring Microscopy and imaging Microbiology and Immunology Regulation and standards Infectious Disease Digital and computational pathology Digital Pathology

Diagnostics, Interoperability, and the AMR Challenge

Key takeaways from a Royal College of Pathologists report and the path ahead for diagnostic leadership in antimicrobial resistance

By Jessica Allerton 09/17/2025 Discussion 7 min read
article Full Article Summary Notecard

Share

Natasha Ratnaraja, Consultant in Infection and Chair of the Medical Microbiology and Virology Specialty Advisory Committee at the UK's Royal College of Pathologists, highlights the pressing issues surrounding antimicrobial resistance (AMR) as discussed in the Public Accounts Committee's 30th Report. Key concerns include improved access to diagnostics, bureaucratic barriers to developing new antimicrobial agents, workforce shortages, and the necessity for effective point-of-care testing. Ratnaraja advocates for increased investment and collaboration to address these challenges and safeguard patient health against AMR.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Jessica Allerton

Deputy Editor, The Pathologist

More Articles by Jessica Allerton

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.